TSE:TST - Telesta Therapeutics Stock Price, News & Analysis

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume292,300 shs
Average Volume212,584 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Telesta Therapeutics Inc. is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer. The Company owns a manufacturing facility for MCNA at Montreal, Quebec. The Company has not generated any revenues.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive TST News and Ratings via Email

Sign-up to receive the latest news and ratings for TST and its competitors with MarketBeat's FREE daily newsletter.

Telesta Therapeutics (TSE:TST) Frequently Asked Questions

What is Telesta Therapeutics' stock symbol?

Telesta Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TST."

Has Telesta Therapeutics been receiving favorable news coverage?

Headlines about TST stock have been trending somewhat positive on Monday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Telesta Therapeutics earned a news impact score of 0.9 on InfoTrie's scale. They also assigned media coverage about the biotechnology company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Telesta Therapeutics.

What other stocks do shareholders of Telesta Therapeutics own?

How do I buy shares of Telesta Therapeutics?

Shares of TST and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Telesta Therapeutics' official website?

The official website for Telesta Therapeutics is http://www.telestatherapeutics.com/.

How can I contact Telesta Therapeutics?

Telesta Therapeutics' mailing address is 231 Dundas Street East, BELLEVILLE, ON K8N 1E2, Canada. The biotechnology company can be reached via phone at +1-514-5876148.

MarketBeat Community Rating for Telesta Therapeutics (TSE TST)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  118
MarketBeat's community ratings are surveys of what our community members think about Telesta Therapeutics and other stocks. Vote "Outperform" if you believe TST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TST will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Featured Article: Fundamental Analysis

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel